Skip to search formSkip to main contentSkip to account menu

MK-0366

Known as: MK 366, MK 0366, MK366 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1983
1983
Norfloxacin is a new orally absorbed quinoline derivative structurally related to nalidixic acid but showing an expanded… 
Highly Cited
1983
Highly Cited
1983
A comparison was made of the in vitro activities of norfloxacin and of nine other orally administered antibacterial agents… 
1983
1983
Norfloxacin (MK-0366) is a new antibacterial agent, closely related to nalidixic acid, with broad spectrum activity against Gram… 
1983
1983
Norfloxacin (MK0366) displayed appreciable activity against the great majority of Gram-negative and Gram-positive bacteria. The… 
1983
1983
We compared the activity of norfloxacin (MK-0366), a new orally absorbable derivative of naladixic acid, with those of other… 
Highly Cited
1982
Highly Cited
1982
The in vitro activity of norfloxacin (MK-0366) compared with that of beta-lactam antibiotics and, where appropriate of gentamicin… 
1982
1982
MK-0366, a new derivative of nalidixic acid, was tested against 250 urinary pathogens including Escherichia coli, Serratia… 
Highly Cited
1982
Highly Cited
1982
A high-performance liquid chromatographic method for the analysis of norfloxacin (MK-366) [1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7… 
Highly Cited
1982
Highly Cited
1982
The in vitro activity of a new oral antimicrobial agent, norfloxacin (MK-0366), was compared with those of nalidixic acid… 
1981
1981
The in vitro activity of a new ora antimicrobial agent, Mk-0366 (AM-715), was compared with those of rosoxacin, ampicillin…